The study performed by Groen et al. [49] confirmed that high COX-2 expression predicted poor prognosis in NSCLC, but the results of more recent study have suggested that the prognostic role of COX-2 in NSCLC needs to be confirmed by further high-quality prospective studies [50]. This evidence concerns the gene PTGS2 and non-small cell lung carcinoma.